Low prevalence of connexin-40 gene variants in atrial tissues and blood from atrial fibrillation subjects

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Tchou, Gregory D ^a   Wirka, Robert C ^b   Van Wagoner, David R ^a   Barnard, John ^c   Chung, Mina K ^a   Smith, Jonathan D ^a  

^a Department of Cell Biology ^*  (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Allelic expression imbalance; Atrial fibrillation; Connexins; Genetics; Ion channels

Indexed keywords

CONNEXIN 40; MESSENGER RNA;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; COHORT ANALYSIS; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSFECTION; GENETIC VARIABILITY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PREVALENCE; RNA STABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ATRIAL FIBRILLATION; BASE SEQUENCE; CONNEXINS; DNA, COMPLEMENTARY; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENETIC VECTORS; HEART ATRIA; HUMANS; INDEL MUTATION; LUCIFERASES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA STABILITY; SEQUENCE ANALYSIS, DNA;

EID: 84868333666     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-102     Document Type: Article

References (27)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285(18):2370-2375. 10.1001/jama.285.18.2370, 11343485.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114(2):119-125. 10.1161/CIRCULATIONAHA.105.595140, 16818816.
3. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009, 104(11):1534-1539. 10.1016/j.amjcard.2009.07.022, 19932788.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22(8):983-988. 10.1161/01.STR.22.8.983, 1866765.
5. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98(10):946-952. 10.1161/01.CIR.98.10.946, 9737513.
6. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002, 113(5):359-364. 10.1016/S0002-9343(02)01236-6, 12401529.
7. Bagwe S, Berenfeld O, Vaidya D, Morley GE, Jalife J. Altered right atrial excitation and propagation in connexin40 knockout mice. Circulation 2005, 112(15):2245-2253. 10.1161/CIRCULATIONAHA.104.527325, 2956435, 16203917.
8. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998, 8(5):299-302. 10.1016/S0960-9822(98)70114-9, 9501070.
9. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006, 354(25):2677-2688. 10.1056/NEJMoa052800, 16790700.
10. Dupays L, Mazurais D, Rucker-Martin C, Calmels T, Bernot D, Cronier L, Malassine A, Gros D, Theveniau-Ruissy M. Genomic organization and alternative transcripts of the human Connexin40 gene. Gene 2003, 305(1):79-90. 10.1016/S0378-1119(02)01229-5, 12594044.
11. Wirka RC, Gore S, Van Wagoner DR, Arking DE, Lubitz SA, Lunetta KL, Benjamin EJ, Alonso A, Ellinor PT, Barnard J, et al. A Common Connexin-40 Gene Promoter Variant Affects Connexin-40 Expression in Human Atria and Is Associated With Atrial Fibrillation. Circ Arrhythm Electrophysiol 2011, 4(1):87-93. 10.1161/CIRCEP.110.959726, 3057452, 21076161.
12. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998, 95(6):2979-2984. 10.1073/pnas.95.6.2979, 19680, 9501201.
13. Gray LC, Hughes TR, van den Berg CW. Binding of human antigen R (HuR) to an AU-rich element (ARE) in the 3′untranslated region (3′UTR) reduces the expression of decay accelerating factor (DAF). Mol Immunol 2010, 47(16):2545-2551. 10.1016/j.molimm.2010.07.002, 20692039.
14. Clifford RJ, Edmonson MN, Nguyen C, Scherpbier T, Hu Y, Buetow KH. Bioinformatics tools for single nucleotide polymorphism discovery and analysis. Ann N Y Acad Sci 2004, 1020:101-109. 10.1196/annals.1310.011, 15208187.
15. Ge B, Gurd S, Gaudin T, Dore C, Lepage P, Harmsen E, Hudson TJ, Pastinen T. Survey of allelic expression using EST mining. Genome Res 2005, 15(11):1584-1591. 10.1101/gr.4023805, 1310646, 16251468.
16. Johnson AD, Zhang Y, Papp AC, Pinsonneault JK, Lim JE, Saffen D, Dai Z, Wang D, Sadee W. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Pharmacogenet Genomics 2008, 18(9):781-791. 10.1097/FPC.0b013e3283050107, 2779843, 18698231.
17. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 2003, 113(2):149-153.
18. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM. Sirotkin K: dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29(1):308-311. 10.1093/nar/29.1.308, 29783, 11125122.
19. A map of human genome variation from population-scale sequencing. Nature 2010, 467(7319):1061-1073. 10.1038/nature09534, 3042601, 20981092.
20. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249. 10.1038/nmeth0410-248, 2855889, 20354512.
21. Levy S, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, Axelrod N, Huang J, Kirkness EF, Denisov G, et al. The diploid genome sequence of an individual human. PLoS Biol 2007, 5(10):e254. 10.1371/journal.pbio.0050254, 1964779, 17803354.
22. Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA, Groenewegen WA, Hauer RN. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 2004, 95(4):e29-e33. 10.1161/01.RES.0000141134.64811.0a, 15297374.
23. Juang JM, Chern YR, Tsai CT, Chiang FT, Lin JL, Hwang JJ, Hsu KL, Tseng CD, Tseng YZ, Lai LP. The association of human connexin 40 genetic polymorphisms with atrial fibrillation. Int J Cardiol 2007, 116(1):107-112. 10.1016/j.ijcard.2006.03.037, 16814413.
24. Sampath P, Mazumder B, Seshadri V, Fox PL. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3′ untranslated region. Mol Cell Biol 2003, 23(5):1509-1519. 10.1128/MCB.23.5.1509-1519.2003, 151701, 12588972.
25. Serre D, Gurd S, Ge B, Sladek R, Sinnett D, Harmsen E, Bibikova M, Chudin E, Barker DL, Dickinson T, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet 2008, 4(2):e1000006. 10.1371/journal.pgen.1000006, 2265535, 18454203.
26. Yang YQ, Liu X, Zhang XL, Wang XH, Tan HW, Shi HF, Jiang WF, Fang WY. Novel connexin40 missense mutations in patients with familial atrial fibrillation. Europace 2010, 12(10):1421-1427. 10.1093/europace/euq274, 20650941.
27. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, Muller-Nurasyid M, Krijthe BP, Lubitz SA, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012, 44(6):670-675. 10.1038/ng.2261, 3366038, 22544366.